APA

Xu P., Chu J., Li Y., Wang Y., He Y., Qi C. & Chang J. (20201021). Novel promising 4-anilinoquinazoline-based derivatives as multi-target RTKs inhibitors: Design, molecular docking, synthesis, and antitumor activities in vitro and vivo. : Bioorganic & medicinal chemistry.

Chicago

Xu Peng, Chu Jiarui, Li Yuqiao, Wang Yaping, He Yong, Qi Chuanmin and Chang Jin. 20201021. Novel promising 4-anilinoquinazoline-based derivatives as multi-target RTKs inhibitors: Design, molecular docking, synthesis, and antitumor activities in vitro and vivo. : Bioorganic & medicinal chemistry.

Harvard

Xu P., Chu J., Li Y., Wang Y., He Y., Qi C. and Chang J. (20201021). Novel promising 4-anilinoquinazoline-based derivatives as multi-target RTKs inhibitors: Design, molecular docking, synthesis, and antitumor activities in vitro and vivo. : Bioorganic & medicinal chemistry.

MLA

Xu Peng, Chu Jiarui, Li Yuqiao, Wang Yaping, He Yong, Qi Chuanmin and Chang Jin. Novel promising 4-anilinoquinazoline-based derivatives as multi-target RTKs inhibitors: Design, molecular docking, synthesis, and antitumor activities in vitro and vivo. : Bioorganic & medicinal chemistry. 20201021.